Research and experimental development on natural sciences and engineering
TRIBUNE THERAPEUTICS AS
Revenue 2024
NOK 7.1m
Operating profit
NOK −20.1m
Equity
NOK 15.8m
Incorporated
2021
Employees
11
Share capital
NOK 200,000
Key figures · 2024
Current ratio
3.10
Equity ratio
70.7%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -283.9% | |
| Net margin (%%) | -278.1% | |
| Return on assets (%%) | -90.3% | |
| Likviditet | ||
| Current ratio | 3.10 | |
| Working capital | 13.7m | |
| Soliditet | ||
| Equity ratio (%%) | 70.7% | |
| Debt-to-equity ratio | 0.41 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.